Lumos Pharma (LUMO)
(Delayed Data from NSDQ)
$3.93 USD
+0.01 (0.26%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $3.90 -0.03 (-0.76%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth D Momentum F VGM
Cash flow Statements
Fiscal Year End for Lumos Pharma, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -34.03 | -31.06 | -30.43 | -5.66 | -42.99 |
Depreciation/Amortization & Depletion | 0.04 | 0.05 | 0.20 | 0.58 | 1.09 |
Net Change from Assets/Liabilities | 0.97 | 2.10 | -2.31 | -3.62 | 4.60 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 1.93 | 2.29 | 2.89 | -14.30 | 7.09 |
Net Cash From Operating Activities | -31.10 | -26.62 | -29.65 | -23.00 | -30.21 |
Property & Equipment | 0.00 | -0.02 | 25.97 | -0.03 | 0.08 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 84.18 | 0.00 |
Investments | 10.74 | -11.34 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 32.50 | 0.00 |
Net Cash from Investing Activities | 10.74 | -11.36 | 25.97 | 116.65 | 0.08 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -1.28 | -0.59 | 0.07 | 0.10 | 0.00 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | -0.06 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | -0.03 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.70 | -0.24 | -0.26 | 0.00 | 0.00 |
Net Cash from Financing Activities | -0.58 | -0.82 | -0.19 | 0.08 | -0.06 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -20.93 | -38.80 | -3.87 | 93.73 | -30.19 |
Cash at Beginning of Period | 56.01 | 94.81 | 98.68 | 4.95 | 120.74 |
Cash at End of Period | 35.08 | 56.01 | 94.81 | 98.68 | 90.55 |
Diluted Net EPS | -4.18 | -3.71 | -3.65 | -0.93 | -10.35 |
Fiscal Year End for Lumos Pharma, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -17.99 | -10.44 | -34.03 | -24.58 | -16.28 |
Depreciation/Amortization & Depletion | 0.00 | 0.00 | 0.04 | 0.03 | 0.02 |
Net Change from Assets/Liabilities | -2.25 | -3.03 | 0.97 | -0.59 | -0.59 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 0.97 | 0.58 | 1.93 | 1.44 | 0.97 |
Net Cash From Operating Activities | -19.27 | -12.89 | -31.10 | -23.70 | -15.88 |
Property & Equipment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 1.00 | 1.00 | 10.74 | 4.57 | -1.38 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 1.00 | 1.00 | 10.74 | 4.57 | -1.38 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.01 | 0.00 | -1.28 | -1.29 | -0.87 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.02 | -0.01 | 0.70 | -0.03 | -0.02 |
Net Cash from Financing Activities | -0.01 | -0.01 | -0.58 | -1.32 | -0.88 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -18.28 | -11.90 | -20.93 | -20.45 | -18.15 |
Cash at Beginning of Period | 35.08 | 35.08 | 56.01 | 56.01 | 56.01 |
Cash at End of Period | 16.80 | 23.18 | 35.08 | 35.56 | 37.86 |
Diluted Net EPS | -0.93 | -1.29 | -1.16 | -1.04 | -1.09 |